Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)

NCT04922281 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT04922281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)
Lead sponsor
University of Rochester
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 28, 2022
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial fibrillation, cardiovascular diseases, heart diseases, pathologic processes